In vivo selection of high-metastatic subline of bladder cancer cell and its characterization

Oncology Research

Volumn 20, Issue 7, 2013, Pages 289-295

  Sugiyama, Naoki ^a   Yoneyama, Mihoko Sutoh ^a,b   Hatakeyama, Shingo ^a   Yamamoto, Hayato ^a   Okamoto, Akiko ^a   Koie, Takuya ^a   Saitoh, Hisao ^b   Yamaya, Kanemitsu ^b   Funyu, Tomihisa ^b   Inoue, Takamitsu ^c   Habuchi, Tomonori ^c   Ohyama, Chikara ^a   Tsuboi, Shigeru ^a,b  

^a HIROSAKI UNIVERSITY   (Japan)

^b Oyokyo Kidney Research Institute   (Japan)

^c AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Extravasation; In vivo selection; Tumor metastasis

Indexed keywords

COMPLEMENTARY DNA; SCLEROPROTEIN;

ARTICLE; BLADDER CANCER; BLADDER METASTASIS; CANCER CELL; CELL ADHESION; EXTRAVASATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 84878903446     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13639794277644     Document Type: Article

References (22)

1. Ehdaie, B.; Smith, S. C.; Theodorescu, D. Personalized medicine in advanced urothelial cancer: When to treat, how to treat and who to treat. Can. Urol. Assoc. J. 3:S232-236; 2009.
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 58:71-96; 2008.
3. Dinney, C. P.; McConkey, D. J.; Millikan, R. E.; Wu, X.; Bar-Eli, M.; Adam, L.; Kamat, A. M.; Siefker-Radtke, A. O.; Tuziak, T.; Sabichi, A. L.; Grossman, H. B.; Benedict, W. F.; Czerniak, B. Focus on bladder cancer. Cancer Cell 6:111-116; 2004.
4. Steeg, P. S. Tumor metastasis: Mechanistic insights and clinical challenges. Nat. Med. 12:895-904; 2006.
5. Kubota, Y.; Nakada, T.; Yanai, H.; Kakizaki, H.; Sasagawa, I.; Watanabe, M. Electropermeabilization in bladder cancer chemotherapy. Cancer Chemother. Pharmacol. 39:67-70; 1996.
6. Hisazumi, H.; Uchibayashi, T.; Katoh, M.; Kobayashi, T.; Nakajima, K.; Naitoh, K.; Misaki, T.; Kuroda, K. Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer. Urol. Res. 9:231-235; 1981.
7. O'Toole, C.; Perlmann, P.; Unsgaard, B.; Almgard, L. E.; Johansson, B.; Moberger, G.; Edsmyr, F. Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation. Int. J. Cancer 10:92-98; 1972.
8. Hatakeyama, S.; Yamamoto, H.; Ohyama, C. Tumor formation assays. Methods Enzymol. 479:397-411; 2010.
9. Tsuboi, S.; Sutoh, M.; Hatakeyama, S.; Hiraoka, N.; Habuchi, T.; Horikawa, Y.; Hashimoto, Y.; Yoneyama, T.; Mori, K.; Koie, T.; Nakamura, T.; Saitoh, H.; Yamaya, K.; Funyu, T.; Fukuda, M.; Ohyama, C. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. EMBO J. 30:3173-3185; 2011.
10. Lanier, L. L. Up on the tightrope: Natural killer cell activation and inhibition. Nat. Immunol. 9:495-502; 2008.
11. Drake, J. M.; Strohbehn, G.; Bair, T. B.; Moreland, J. G.; Henry, M. D. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol. Biol. Cell 20:2207-2217; 2009.
12. Ingber, D. E. Can cancer be reversed by engineering the tumor microenvironment? Semin. Cancer Biol. 18:356-364; 2008.
13. Elkin, M.; Vlodavsky, I. Tail vein assay of cancer metastasis. Curr. Protoc. Cell Biol. Chapter 19: Unit 19.2; 2001.
14. Kleinman, H.; K.; Jacob, K. Invasion assays. Curr. Protoc. Cell Biol. Chapter 12: Unit 12.2; 2001.
15. Kikkawa, H.; Kaihou, M.; Horaguchi, N.; Uchida, T.; Imafuku, H.; Takiguchi, A.; Yamazaki, Y.; Koike, C.; Kuruto, R.; Kakiuchi, T.; Tsukada, H.; Takada, Y.; Matsuura, N.; Oku, N. Role of integrin α(v)β3 in the early phase of liver metastasis: PET and IVM analyses. Clin. Exp. Metastasis 19:717-725; 2002.
16. Klemke, M.; Weschenfelder, T.; Konstandin, M. H.; Samstag, Y. High affinity interaction of integrin α4β1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J. Cell Physiol. 212:368-374; 2007.
17. Bauer, K.; Mierke, C.; Behrens, J. Expression profiling reveals genes associated with transendothelial migration of tumor cells: A functional role for αvβ3 integrin. Int. J. Cancer 121:1910-1918; 2007.
18. Brooks, S. A.; Lomax-Browne, H. J.; Carter, T. M.; Kinch,; C. E.; Hall, D. M. Molecular interactions in cancer cell metastasis. Acta Histochem. 112:3-25; 2010.
19. Fidler, I. J. Selection of successive tumour lines for metastasis. Nat. New Biol. 242:148-149; 1973.
20. Morikawa, K.; Walker, S. M.; Jessup, J. M.; Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 48:1943-1948; 1988.
21. Minn, A. J.; Kang, Y.; Serganova, I.; Gupta, G. P.; Giri, D. D.; Doubrovin, M.; Ponomarev, V.; Gerald, W. L.; Blasberg, R.; Massague, J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115:44-55; 2005.
22. Said, N.; Smith, S.; Sanchez-Carbayo, M.; Theodorescu, D. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J. Clin. Invest. 121:132-147; 2011.